Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Scherr, D; Sharma, K; Dalal, D; Spragg, D; Chilukuri, K; Cheng, A; Dong, J; Henrikson, CA; Nazarian, S; Berger, RD; Calkins, H; Marine, JE.
Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation.
J Cardiovasc Electrophysiol. 2009; 20(12):1357-1363
Doi: 10.1111/j.1540-8167.2009.01540.x
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Scherr Daniel
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Cerebrovascular accident (CVA) is a serious complication of catheter ablation of atrial fibrillation (AF). The incidence and clinical predictors of periprocedural CVA in patients undergoing AF ablation are not fully understood. This study included 721 cases (age 57 +/- 11 years; 23% female; 345 persistent AF) in 579 consecutive patients referred for AF ablation. Periprocedural CVA was defined as onset of a new neurologic deficit that occurred anytime between the start of the procedure and 30 days after the AF ablation, and was confirmed by a neurologist. Cranial imaging with CT and/or MRI was performed in each case. Patients were anticoagulated with warfarin for at least 4 weeks pre- and immediately postprocedure and were bridged with enoxaparin. Transesophageal echocardiography was performed within 24 hours prior to ablation in all cases. Periprocedural CVA occurred in 10 of 721 cases (1.4%). The risk of periprocedural CVA did not vary significantly during the course of the study. Among these 10 patients (age 62 +/- 11 years; 1 female; 5 persistent AF), 6 manifested neurological deficits within 24 hours, 3 after 24-48 hours, and 1 patient had a CVA 6 days following AF ablation despite a therapeutic INR level. All CVAs were ischemic. Five patients had residual deficits after 30 days. Four of 43 patients (9.3%) with a prior history of CVA had periprocedural CVA. Periprocedural CVA occurred in 0.3%, 1.0%, and 4.7% of patients with CHADS(2) scores of 0, 1, and > or = 2 (P < 0.001). In 2 separate multivariate analyses, a CHADS(2) score > or = 2 (OR 7.1, P = 0.02) and history of CVA (OR 9.5, P < 0.01) remained independent predictors of periprocedural CVA. Despite periprocedural anticoagulation and transesophageal echocardiography, we found a 1.4% incidence of periprocedural CVA in AF ablation patients. A CHADS(2) score > or = 2 and a history of CVA are independent predictors of CVA after AF ablation. The CVA risk is low in patients with CHADS(2) score of 0.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Aged -
- Atrial Fibrillation - surgery
- Catheter Ablation - statistics & numerical data
- Comorbidity -
- Female -
- Humans -
- Incidence -
- Middle Aged -
- Postoperative Complications - epidemiology
- Prognosis -
- Retrospective Studies -
- Risk Assessment - methods
- Risk Factors -
- Stroke - epidemiology
- Treatment Outcome -
- United States -
- Find related publications in this database (Keywords)
- ablation
- atrial fibrillation
- complication
- embolism
- cerebrovascular accident
- warfarin